ILM, R., RV, R., AJ, C., EA, R., AM, M., ACJ, v. A., . . . CU, B. (2022). Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma. JAMA surgery, 157(4), 335. https://doi.org/10.1001/jamasurg.2021.7554
Chicago Style (17th ed.) CitationILM, Reijers, et al. "Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma." JAMA Surgery 157, no. 4 (2022): 335. https://doi.org/10.1001/jamasurg.2021.7554.
MLA (9th ed.) CitationILM, Reijers, et al. "Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma." JAMA Surgery, vol. 157, no. 4, 2022, p. 335, https://doi.org/10.1001/jamasurg.2021.7554.